Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-01-03 @ 2:36 AM
Study NCT ID:
NCT04643002
Status:
RECRUITING
Last Update Posted:
2025-08-11
First Post:
2020-10-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
Sponsor:
Sanofi
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ACT16482
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None